References
- Wilson A M, Blumsohm A, Jung R T, Lipworth B J. Asthma and Cushing's syndrome. Chest 2000; 117: 593–594
- Pasmar J S, Howell T, Kelly J, Bilton D. Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax 2002; 57: 749–750
- Berbel Garcia A, Latorre Ibarra A, Porta Etessam J, Martinez Salio A, Perez Martinez D, Siaz Diaz R, Toledo Heras M. Protease inhibitor‐induced carbamazepine toxicity. Clin Neuropharmacol 2000; 23: 216–218
- Meibohm B, Möllmann H, Wagner M, Hochhaus G, Möllmann A, Derendorf H. The clinical pharmacology of fluticasone propionate. Rev Contemp Pharmacother 1998; 9: 535–549
- Hillebrand‐Haverkort M E, Prummel M F, Ten Veen J H. Ritonavir‐induced Cushing's syndrome in a patient treated with nasal fluticasone. AIDS 1999; 13: 1803
- Poirier C D, Inhaber N, Lalonde R G, Ernst P. Prevalence of bronchial hyperresponsiveness among HIV‐infected men. Am J Respir Crit Care Med 2001; 164: 542–545